FindTrial
Sign In

Optimal bolus interval of sufentanil in latent phase of first labor stage for epidural analgesia and dural puncture epidural analgesia

Optimal bolus interval of sufentanil in latent phase of first labor stage for epidural analgesia and dural puncture epidural analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077994
Enrollment
Unknown
Registered
2023-11-27
Start date
2023-11-27
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor analgesia

Interventions

E:epidural analgesia
DPE:dural puncture epidural analgesia

Sponsors

INTERNATIONAL PEACE MATERNITY & CHILD HEALTH HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: aged 20 to 40, American Society of Anesthesiologists physical status II, singleton parturient, 37 to 42 weeks’ gestation, cervical dilation of 1~3 cm, a numeric rating scale (NRS) of =6,require labor analgesia

Exclusion criteria

Exclusion criteria: Patients with contraindications to neuraxial labor analgesia, allergic to ropivacaine or sufentanil, gestational hypertension, preeclampsia, gestational diabetes, known major fetal abnormalities, body mass index >36 kg/m2 , or the receipt of opioids or sedatives before epidural analgesia, patients with history of drug abuse were excluded.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale score;—

Secondary

MeasureTime frame
anesthesia block plane;—

Countries

China

Contacts

Public ContactYe Shanshan

INTERNATIONAL PEACE MATERNITY & CHILD HEALTH HOSPITAL

spade__q@163.com+86 136 8177 7249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026